Research Scientist, Koch Institute for Integrative Cancer Research at MIT, USA
 Commentary   
								
																Transition to Imitated Therapies Improved the Prognosis 
																Author(s): Guangan Hu*             
								
								
																DOI:
								10.37421/aso.2022.8.02															  
Archives of Surgical Oncology received 37 citations as per Google Scholar report